Gordinier ME - Search Results

1

Quantitative analysis of transforming growth factor beta 1 and 2 in ovarian carcinoma.

Gordinier ME, Zhang HZ, Patenia R, Levy LB, Atkinson EN, Nash MA, Katz RL, Platsoucas CD, Freedman RS. Gordinier ME, et al. Clin Cancer Res. 1999 Sep;5(9):2498-505. Clin Cancer Res. 1999. PMID: 10499625

2

The role of cytokines in both the normal and malignant ovary.

Nash MA, Ferrandina G, Gordinier M, Loercher A, Freedman RS. Nash MA, et al. Endocr Relat Cancer. 1999 Mar;6(1):93-107. doi: 10.1677/erc.0.0060093. Endocr Relat Cancer. 1999. PMID: 10732792 Review.

3

Thiotepa in combination with cisplatin for primary epithelial ovarian cancer: a phase II study.

Gordinier ME, Kudelka AP, Kavanagh JJ, Wharton JT, Freedman RS. Gordinier ME, et al. Int J Gynecol Cancer. 2002 Nov-Dec;12(6):710-4. doi: 10.1046/j.1525-1438.2002.01138.x. Int J Gynecol Cancer. 2002. PMID: 12445247 Clinical Trial.

4

Mentorship and productivity among gynecologic oncology fellows.

Ramondetta LM, Bodurka DC, Tortolero-Luna G, Gordinier M, Wolf JK, Gershenson DM, Sciscione AC. Ramondetta LM, et al. J Cancer Educ. 2003 Spring;18(1):15-9. doi: 10.1207/s15430154jce1801_9. J Cancer Educ. 2003. PMID: 12825629

5

Hyperthermic intraperitoneal chemotherapy in conjunction with surgery for the treatment of recurrent ovarian carcinoma.

Helm CW, Randall-Whitis L, Martin RS 3rd, Metzinger DS, Gordinier ME, Parker LP, Edwards RP. Helm CW, et al. Among authors: gordinier me. Gynecol Oncol. 2007 Apr;105(1):90-6. doi: 10.1016/j.ygyno.2006.10.051. Epub 2006 Dec 14. Gynecol Oncol. 2007. PMID: 17173957

6

Cytoreduction and intraperitoneal heated chemotherapy for the treatment of endometrial carcinoma recurrent within the peritoneal cavity.

Helm CW, Toler CR, Martin RS 3rd, Gordinier ME, Parker LP, Metzinger DS, Edwards RP. Helm CW, et al. Among authors: gordinier me. Int J Gynecol Cancer. 2007 Jan-Feb;17(1):204-9. doi: 10.1111/j.1525-1438.2006.00751.x. Int J Gynecol Cancer. 2007. PMID: 17291254

7

Retraction of an intraperitoneal chemotherapy port: a case report and literature review.

Pendergrass M, Gordinier ME, Parker LP, Metzinger DS, Helm CW. Pendergrass M, et al. Among authors: gordinier me. Int J Gynecol Cancer. 2007 Sep-Oct;17(5):1131-3. doi: 10.1111/j.1525-1438.2007.00910.x. Epub 2007 Mar 26. Int J Gynecol Cancer. 2007. PMID: 17386044 Review.

8

Oral thalidomide as palliative chemotherapy in women with advanced ovarian cancer.

Gordinier ME, Dizon DS, Weitzen S, Disilvestro PA, Moore RG, Granai CO. Gordinier ME, et al. J Palliat Med. 2007 Feb;10(1):61-6. doi: 10.1089/jpm.2006.0083. J Palliat Med. 2007. PMID: 17298255

9

Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study.

Landen CN, Buckanovich RJ, Sill MW, Mannel RS, Walker JL, DiSilvestro PA, Mathews CA, Mutch DG, Hernandez ML, Martin LP, Bishop E, Gill SE, Gordinier ME, Burger RA, Aghajanian C, Liu JF, Moore KN, Bookman MA. Landen CN, et al. Among authors: gordinier me. J Clin Oncol. 2024 Jul 20;42(21):2537-2545. doi: 10.1200/JCO.23.02076. Epub 2024 May 22. J Clin Oncol. 2024. PMID: 38776484 Clinical Trial.

10

Caelyx/Doxil for the treatment of metastatic ovarian and breast cancer.

Tejada-Berges T, Granai CO, Gordinier M, Gajewski W. Tejada-Berges T, et al. Expert Rev Anticancer Ther. 2002 Apr;2(2):143-50. doi: 10.1586/14737140.2.2.143. Expert Rev Anticancer Ther. 2002. PMID: 12113236 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters